GRALISE ER 750 MG TABLET

gabapentin
$15.1857per EA
High Outlier

Strength

750 mg/1

NDC

52427085060

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

9/17/2025

Active Ingredients

GABAPENTIN

Approval Type

New Drug (NDA)

FDA Application

NDA022544

On Market Since

12/31/2023

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.6%

3Y

N/A

5Y

N/A

All

-0.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.